These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 33662435

  • 1. Hyperbaric oxygen therapy restores cognitive function and hippocampal pathologies in both aging and aging-obese rats.
    Shwe T, Bo-Htay C, Ongnok B, Chunchai T, Jaiwongkam T, Kerdphoo S, Kumfu S, Pratchayasakul W, Pattarasakulchai T, Chattipakorn N, Chattipakorn SC.
    Mech Ageing Dev; 2021 Apr; 195():111465. PubMed ID: 33662435
    [Abstract] [Full Text] [Related]

  • 2. Hyperbaric oxygen therapy improves age induced bone dyshomeostasis in non-obese and obese conditions.
    Imerb N, Thonusin C, Pratchayasakul W, Arunsak B, Nawara W, Aeimlapa R, Charoenphandhu N, Chattipakorn N, Chattipakorn SC.
    Life Sci; 2022 Apr 15; 295():120406. PubMed ID: 35182555
    [Abstract] [Full Text] [Related]

  • 3. Gut dysbiosis develops before metabolic disturbance and cognitive decline in high-fat diet-induced obese condition.
    Saiyasit N, Chunchai T, Prus D, Suparan K, Pittayapong P, Apaijai N, Pratchayasakul W, Sripetchwandee J, Chattipakorn M D Ph D N, Chattipakorn SC.
    Nutrition; 2020 Jan 15; 69():110576. PubMed ID: 31580986
    [Abstract] [Full Text] [Related]

  • 4. FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats.
    Sa-Nguanmoo P, Tanajak P, Kerdphoo S, Satjaritanun P, Wang X, Liang G, Li X, Jiang C, Pratchayasakul W, Chattipakorn N, Chattipakorn SC.
    Horm Behav; 2016 Sep 15; 85():86-95. PubMed ID: 27566237
    [Abstract] [Full Text] [Related]

  • 5. D-galactose-induced aging does not cause further deterioration in brain pathologies and cognitive decline in the obese condition.
    Shwe T, Bo-Htay C, Leech T, Ongnok B, Jaiwongkum T, Kerdphoo S, Palee S, Pratchayasakul W, Chattipakorn N, Chattipakorn SC.
    Exp Gerontol; 2020 Sep 15; 138():111001. PubMed ID: 32522583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dipeptidyl peptidase 4 inhibitor improves brain insulin sensitivity, but fails to prevent cognitive impairment in orchiectomy obese rats.
    Pintana H, Pongkan W, Pratchayasakul W, Chattipakorn N, Chattipakorn SC.
    J Endocrinol; 2015 Aug 15; 226(2):M1-M11. PubMed ID: 26016746
    [Abstract] [Full Text] [Related]

  • 8. Blocking Brain Myeloid Differentiation Factor 2-Toll-like Receptor 4 Signaling Improves Cognition by Diminishing Brain Pathologies and Preserving Adult Hippocampal Neurogenesis in Obese Rats.
    Oo TT, Sumneang N, Chunchai T, Apaijai N, Pratchayasakul W, Liang G, Chattipakorn N, Chattipakorn SC.
    J Neuroimmune Pharmacol; 2024 Oct 07; 19(1):51. PubMed ID: 39373789
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined dipeptidyl peptidase-4 inhibitor with low-dose testosterone exerts greater efficacy than monotherapy on improving brain function in orchiectomized obese rats.
    Keawtep P, Pratchayasakul W, Arinno A, Apaijai N, Chunchai T, Kerdphoo S, Jaiwongkum T, Chattipakorn N, Chattipakorn SC.
    Exp Gerontol; 2019 Aug 07; 123():45-56. PubMed ID: 31125595
    [Abstract] [Full Text] [Related]

  • 14. Not only metformin, but also D-allulose, alleviates metabolic disturbance and cognitive decline in prediabetic rats.
    Pratchayasakul W, Jinawong K, Pongkan W, Jaiwongkam T, Arunsak B, Chunchai T, Tokuda M, Chattipakorn N, Chattipakorn SC.
    Nutr Neurosci; 2022 Jun 07; 25(6):1115-1127. PubMed ID: 33151133
    [Abstract] [Full Text] [Related]

  • 15. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
    Sa-Nguanmoo P, Tanajak P, Kerdphoo S, Jaiwongkam T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC.
    Toxicol Appl Pharmacol; 2017 Oct 15; 333():43-50. PubMed ID: 28807765
    [Abstract] [Full Text] [Related]

  • 16. Testosterone deprivation has neither additive nor synergistic effects with obesity on the cognitive impairment in orchiectomized and/or obese male rats.
    Pintana H, Pratchayasakul W, Sa-nguanmoo P, Pongkan W, Tawinvisan R, Chattipakorn N, Chattipakorn SC.
    Metabolism; 2016 Feb 15; 65(2):54-67. PubMed ID: 26773929
    [Abstract] [Full Text] [Related]

  • 17. Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats.
    Saiyasit N, Chunchai T, Jaiwongkam T, Kerdphoo S, Apaijai N, Pratchayasakul W, Sripetchwandee J, Chattipakorn N, Chattipakorn SC.
    J Endocrinol; 2021 Jan 15; 248(1):59-74. PubMed ID: 33112810
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats.
    Arunsak B, Pratchayasakul W, Amput P, Chattipakorn K, Tosukhowong T, Kerdphoo S, Jaiwongkum T, Thonusin C, Palee S, Chattipakorn N, Chattipakorn SC.
    Arch Biochem Biophys; 2020 Aug 15; 689():108470. PubMed ID: 32592802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.